Transvaginal mesh is a plastic, net-like implant which supports the muscles and tissues of the pelvis to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI). These implants are surgically implanted and include bladder slings and tension-free vaginal tape. The U.S. Food and Drug Administration (FDA) approved surgical mesh in 2001.
In July 2011, the FDA issued a statement warning of the risk of serious complications with transvaginal mesh, including infection and mesh erosion. In 2016, the FDA reclassified transvaginal mesh as a Class III device, meaning it now requires premarket approval before being sold.
Transvaginal Mesh Complications
Transvaginal mesh implants can cause serious complications, even when doctors follow the manufacturer’s instructions for proper use. These implants can cause serious, potentially fatal, complications to women who have them implanted.
Common transvaginal mesh problems include:
- Vaginal wall erosion and scarring
- Pain and bleeding
- Perforations of the bladder, bowel or blood vessels
- Urinary problems
In cases where transvaginal mesh implants cause complications, surgery may be required to reduce pain and remove the problematic materials. Since transvaginal mesh is meant to be a permanent implant, it can be difficult to remove and potentially increase the patient’s risk of injury when it is extracted. Furthermore, tissues grow into and around the mesh making it difficult to remove with causing damage.
If you or a loved one suffered injuries as a result of transvaginal mesh, you may be entitled to compensation. Contact us today to schedule a free consultation.
Although there have been reported injuries with this device, the FDA has not recalled its approval at this time. Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death.